What Australian biotech needs to compete globally

Australia aims to be more than a destination for clinical trials, and an influx of cash is helping the country’s biotech sector fill its translational gap. But like other emerging biotech hubs, talent and a higher appetite for risk will be needed to compete on a global scale.

Over the past decade, Australian biotech has seen marked growth, due in large part to a series of government-backed initiatives and funds designed to boost its translational science, which has historically lagged its academic research and clinical trial capabilities...